Use of igf-1 and nt-3 in the treatment of x-linked adrenoleukodystrophy

The present invention is directed to new compositions uses thereof and related methods for the treatment of X- linked adrenoleukodystrophy.


Year:
2010
Keywords:
Note:
Alternative title(s) : (fr) Utilisation de igf-1 et de nt-3 dans le traitement d'une adrénoleucodystrophie à liaison x
Other identifiers:
EPO Family ID: 42104387
Patent number(s):
Laboratories:
LEN
TTO




 Record created 2015-09-22, last modified 2020-10-25


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)